Signal Explorer

New York Jurisdiction Clause Non Assignment Clause Registration Rights Piggyback Provision Amendment Modification Waiver Clause Director Officer Indemnification Provision Closing Deliverables Specified

Nasdaq Minimum Bid Price Delisting Notice Credit Agreement Schedule Amendment Closing Logistics Specified Reverse Stock Split Effected Nyse Listing Disclosure

Fair Value Hierarchy Disclosure Restrictive Debt Covenants Disclosure Net Loss Reported Segment Aggregation Disclosure Cash Flow Statement Investing Activities Nasdaq Minimum Bid Price Delisting Notice Liquidity Position Snapshot Disclosed Nyse Listing Disclosure Financing Activities Cash Flow Disclosure Registration Rights Piggyback Provision Personnel Cost Decrease Disclosure Capital Raising Uncertainty Disclosed Convertible Debt Conversion Convertible Notes Conversion Terms Disclosed Use Of Proceeds Disclosure

Corporate Authority Representation Confidential Information Return Obligation Covid19 Pandemic Uncertainty Disclosure Hazardous Materials Definition New York Jurisdiction Clause Anti Takeover Provision Disclosure Capital Raising Uncertainty Disclosed Nasdaq Minimum Bid Price Delisting Notice Fcpa Compliance Representation Corporate Organization And Standing Representation Anti Takeover Poison Pill No Broker Fees Representation Amendment Modification Waiver Clause Section 409A Compliance Statement

Ai Drug Discovery Investment

New York Jurisdiction Clause Change Of Control Redemption Provision Amendment Modification Waiver Clause Nyse Listing Disclosure Successor Agent Appointment Provision Interest Payment Date Business Day Postponement Employment Termination Upon Death

Tenant Restoration Obligation Net Loss Reported Liquidity Position Snapshot Disclosed Amendment Modification Waiver Clause Shareholder Dilution Warning Nyse Listing Disclosure Cash Flow Statement Investing Activities Financing Activities Cash Flow Disclosure Capital Raising Uncertainty Disclosed Convertible Debt Conversion Revenue Decline Explanation Convertible Notes Conversion Terms Disclosed Ipo Or Capital Raising Completion Survival Of Representations Warranties Clause Quarterly Dividend Declared

Revenue Decline Explanation Net Loss Reported Interim Data Positive Fast Track Granted Administrative Efficiency Use Of Proceeds Disclosure Rmat Designation Received Fast Track Designation Received Patient Retention High Fda Aligned Orphan Status Granted

Demand Softening

Clinical Trial Result Lead Asset Progress

Orphan Drug Designation

New York Jurisdiction Clause Restrictive Debt Covenants Disclosure Corporate Authority Representation Change Of Control Redemption Provision Fcpa Compliance Representation Convertible Debt Conversion Corporate Organization And Standing Representation Convertible Notes Conversion Terms Disclosed Non Assignment Clause Conflicted Defense Counsel Provision Nyse Listing Disclosure Sanctions Compliance Representation Amendment Modification Waiver Clause Registration Rights Piggyback Provision Closing Deliverables Specified

Nyse Listing Disclosure

Auditor Appointment Ratification Covid19 Pandemic Uncertainty Disclosure Fair Value Hierarchy Disclosure Cash Flow Statement Investing Activities Net Loss Reported Warrant Valued Black Scholes Goodwill Impairment Nyse Listing Disclosure Impairment Charge Breakdown Lease Rou Incremental Borrowing Rate Disclosure Rsu Psu Vesting Schedule Disclosed Geopolitical Risk Disclosure 2023 2024 Financing Activities Cash Flow Disclosure Codm Segment Reporting Disclosure Material Weakness In Internal Controls Disclosed

Net Loss Reported Liquidity Position Snapshot Disclosed Interim Data Positive Personnel Cost Decrease Disclosure Kol Endorsement Administrative Efficiency Fda Aligned Expanded Access Program Active Enrollment Ahead Of Schedule Fast Track Granted Protocol Amended

Clinical Trial Result Lead Asset Progress Clinical Hold

Clinical Hold Active

Operating Lease Rent Expense Disclosed Tenant Restoration Obligation